Headsafe

medical devices

About

Headsafe is an Australian medtech company founded in 2017, dedicated to developing innovative medical devices for brain injury assessment. Its primary product, Nurochek, is a portable device that has received FDA clearance. Nurochek utilizes advanced Visual Evoked Potential (VEP) technology integrated with EEG to provide rapid and objective assessments of concussions and other brain injuries. The device delivers results in about two minutes, making it suitable for use in healthcare facilities, sports fields, and emergency services. The company aims to set a new standard in concussion assessment and has conducted clinical research involving over a thousand subjects across Australia, the US, and New Zealand. Headsafe is committed to improving brain injury diagnosis and management, with a focus on regulatory compliance and quality assurance. The company is preparing for growth and plans to expand its market presence in the U.S. as it continues to support healthcare providers, sports organizations, and emergency services in managing brain injuries effectively.

Technologies

Cloudflare DNS 1&1 Email Provider CloudFlare Hosting reCAPTCHA Vimeo WordPress.org Mobile Friendly Remote AI

Keywords

neurology medical devices biotechnology medical equipment manufacturing machine learning algorithms concussion baseline-free test clinical trials portable eeg headset brain function analysis b2b medical device regulatory approval health insurance neurodiagnostic cloud platform cloud ai health analytics neuroscience research visual evoked potential analysis concussion ai classifier digital health tools mtbi diagnosis eeg-based assessment medical equipment and supplies manufacturing objective brain testing cloud data storage medical device innovation mental health brain injury diagnosis healthcare clinical research in neurology neurocognitive testing neurodiagnostics

Location

Sydney, New South Wales, Australia

Related Companies

Companies in the same industry